Forte Capital LLC ADV trimmed its holdings in shares of Cardinal Health Inc (NYSE:CAH) by 16.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,044 shares of the company’s stock after selling 1,021 shares during the quarter. Forte Capital LLC ADV’s holdings in Cardinal Health were worth $309,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in CAH. Ameriprise Financial Inc. lifted its position in shares of Cardinal Health by 38.6% during the third quarter. Ameriprise Financial Inc. now owns 4,930,457 shares of the company’s stock worth $329,964,000 after purchasing an additional 1,373,334 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Cardinal Health by 58.7% during the third quarter. American Century Companies Inc. now owns 2,976,776 shares of the company’s stock valued at $199,206,000 after buying an additional 1,100,507 shares during the period. HealthCor Management L.P. purchased a new position in shares of Cardinal Health during the second quarter valued at $84,496,000. Pzena Investment Management LLC increased its stake in shares of Cardinal Health by 70.6% during the third quarter. Pzena Investment Management LLC now owns 1,806,522 shares of the company’s stock valued at $120,892,000 after buying an additional 747,718 shares during the period. Finally, Boston Partners increased its stake in shares of Cardinal Health by 31.0% during the third quarter. Boston Partners now owns 2,918,367 shares of the company’s stock valued at $195,297,000 after buying an additional 690,827 shares during the period. Institutional investors and hedge funds own 88.23% of the company’s stock.

Cardinal Health Inc (NYSE CAH) opened at $73.51 on Tuesday. Cardinal Health Inc has a 52 week low of $54.66 and a 52 week high of $84.88. The company has a quick ratio of 0.52, a current ratio of 1.06 and a debt-to-equity ratio of 1.35. The stock has a market capitalization of $22,623.14, a PE ratio of 21.37, a price-to-earnings-growth ratio of 1.65 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last posted its earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The company had revenue of $32.64 billion for the quarter, compared to analyst estimates of $33.48 billion. During the same quarter in the previous year, the firm earned $1.24 earnings per share. The firm’s quarterly revenue was up 1.9% compared to the same quarter last year. equities research analysts expect that Cardinal Health Inc will post 5.12 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd were paid a $0.4624 dividend. The ex-dividend date was Friday, December 29th. This represents a $1.85 annualized dividend and a yield of 2.52%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.78%.

Several equities analysts have recently commented on the company. Robert W. Baird restated a “hold” rating and set a $80.00 price target on shares of Cardinal Health in a research note on Wednesday, January 17th. Evercore ISI assumed coverage on Cardinal Health in a research note on Thursday, January 4th. They set an “in-line” rating and a $67.00 price target on the stock. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research note on Thursday, October 12th. ValuEngine lowered Cardinal Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Jefferies Group cut their price target on Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a research note on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $73.58.

COPYRIGHT VIOLATION NOTICE: This report was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.dailypolitical.com/2018/01/23/cardinal-health-inc-cah-shares-sold-by-forte-capital-llc-adv.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.